Efficacy of VEGF and VEGFR pathway inhibitors in the treatment of advanced gastric cancer
10.3760/cma.j.issn.1673-422X.2017.05.018
- VernacularTitle:VEGF和VEGFR通路抑制剂在晚期胃癌治疗中的疗效
- Author:
Maoji LI
;
Lei JIANG
;
Quanlin GUAN
- Keywords:
Vascular endothelial growth factors;
Receptors,vascular endothelial growth factor;
Stomach neoplasms
- From:
Journal of International Oncology
2017;44(5):393-396
- CountryChina
- Language:Chinese
-
Abstract:
Anti-neovascularization is an important research direction in the current treatment of gastric cancer.The inhibitors of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) are main research focus.At present,the inhibitors of the pathways of VEGF and VEGFR in the treatment of advanced gastric cancer include bevacizumab,ramucirumab,apatinib,regorafenib,sorafenib,et al.These drugs provide more possibilities for the treatment of advanced gastric cancer.
